Wealth Dimensions Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$736K Sell
26,228
-4,837
-16% -$129K 0.14% 76
2025
Q4
$774K Buy
31,065
+1,353
+5% +$34.1K 0.15% 73
2025
Q3
$757K Sell
29,712
-199
-0.7% -$4.91K 0.16% 78
2025
Q2
$725K Buy
29,911
+128
+0.4% +$2.98K 0.16% 78
2025
Q1
$755K Buy
29,783
+1,938
+7% +$50.7K 0.18% 69
2024
Q4
$739K Buy
27,845
+3,552
+15% +$96.3K 0.18% 70
2024
Q3
$703K Buy
24,293
+502
+2% +$14.6K 0.18% 67
2024
Q2
$666K Buy
23,791
+454
+2% +$12.5K 0.19% 66
2024
Q1
$648K Buy
23,337
+7,481
+47% +$208K 0.19% 65
2023
Q4
$456K Sell
15,856
-3,391
-18% -$103K 0.14% 81
2023
Q3
$638K Sell
19,247
-122
-0.6% -$4.31K 0.23% 58
2023
Q2
$710K Buy
19,369
+568
+3% +$22.1K 0.26% 52
2023
Q1
$767K Buy
18,801
+1,069
+6% +$46.2K 0.3% 47
2022
Q4
$909K Buy
17,732
+1,089
+7% +$52.2K 0.37% 43
2022
Q3
$728K Sell
16,643
-26
-0.2% -$1.26K 0.36% 42
2022
Q2
$874K Sell
16,669
-23
-0.1% -$1.17K 0.41% 39
2022
Q1
$864K Sell
16,692
-963
-5% -$50K 0.4% 45
2021
Q4
$1.04M Sell
17,655
-331
-2% -$16.4K 0.51% 30
2021
Q3
$774K Sell
17,986
-361
-2% -$16K 0.5% 40
2021
Q2
$718K Buy
18,347
+53
+0.3% +$2.06K 0.49% 40
2021
Q1
$663K Buy
18,294
+630
+4% +$22.4K 0.51% 38
2020
Q4
$650K Buy
+17,664
New +$648K 0.56% 31

Other funds holding PFE

Wealth Dimensions Group's PFE Position: Q1 2026 in Review

Wealth Dimensions Group reduced its Pfizer (PFE) stake by 16% in Q1 2026, selling an estimated $129K and leaving 26,228 shares worth $736K. The position accounts for 0.14% of the portfolio, ranked #76.

Wealth Dimensions Group first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.04M in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Wealth Dimensions Group held 26,228 shares of Pfizer worth $736K as of Q1 2026.
  • Wealth Dimensions Group sold 4,837 Pfizer shares in Q1 2026, an estimated $129K.
  • Pfizer made up 0.14% of Wealth Dimensions Group's portfolio in Q1 2026, its #76 holding.
  • Wealth Dimensions Group first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
  • Wealth Dimensions Group's Pfizer position peaked at $1.04M in Q4 2021.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Wealth Dimensions Group's 13F filing for Q1 2026, filed 12 May 2026.